St Erik Eye Hospital
- Address
- Eugeniavagen 12
Sponsor Overview
Specializations
Retinal Degeneration
Research activity includes geographic atrophy secondary to dry age-related macular degeneration, with attention to disease-related loss of central vision and progressive retinal pigment epithelium damage.
- Geographic atrophy
- Dry age-related macular degeneration
- Retinal pigment epithelium
Clinical interest is centered on preserving visual function in advanced degenerative macular disease.
Uveal Melanoma
Clinical research also focuses on uveal melanoma, with interest in disease control after local treatment and the risk of distant spread, including metastatic disease.
- Uveal melanoma
- Metastases
- Adjuvant therapy
The trial portfolio reflects concern for long-term oncologic outcomes in ocular malignancy.
Ocular Oncology
The sponsor’s trial activity spans ocular oncology, linking eye disease management with cancer surveillance and recurrence prevention in tumors arising within the eye.
- Ocular oncology
- Eye cancer
- Metastatic risk
This area includes clinical questions relevant to follow-up care and systemic spread in patients with intraocular malignancy.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| AMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study | Sweden | Recruiting |
| Evaluation of CellThRPE1 in Patients with Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration | Sweden | Not Yet Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 2 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases2 trials138 other sponsors
Partnered Research Centres
2 centres- Address
- Eugeniavagen 12, 171 64 Solna
- Address
- Polhemsgatan 50, Vastermalm, 112 30 Stockholm
Want to get in touch with this sponsor?
Send a question and we'll pass it on to St Erik Eye Hospital.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

